Are breast cancers in young women qualitatively distinct?
- 1 May 1997
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 349 (9064), 1488-1489
- https://doi.org/10.1016/s0140-6736(97)22021-0
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- The genetic attributable risk of breast and ovarian cancerCancer, 1996
- Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkageCancer, 1996
- Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapyNature Medicine, 1995
- Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome 17q12–21British Journal of Surgery, 1994
- c-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast CancerNew England Journal of Medicine, 1994
- Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.Journal of Clinical Oncology, 1992
- HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma.Journal of Clinical Oncology, 1992
- Cell kinetics as a prognostic marker in node-negative breast cancerCancer, 1985